Syndax Pharmaceuticals (SNDX) Accumulated Depreciation & Amortization (2016 - 2023)
Historic Accumulated Depreciation & Amortization for Syndax Pharmaceuticals (SNDX) over the last 10 years, with Q4 2024 value amounting to $419000.0.
- Syndax Pharmaceuticals' Accumulated Depreciation & Amortization rose 194.65% to $419000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $419000.0, marking a year-over-year increase of 194.65%. This contributed to the annual value of $419000.0 for FY2024, which is 194.65% up from last year.
- According to the latest figures from Q4 2024, Syndax Pharmaceuticals' Accumulated Depreciation & Amortization is $419000.0, which was up 194.65% from $411000.0 recorded in Q4 2023.
- Over the past 5 years, Syndax Pharmaceuticals' Accumulated Depreciation & Amortization peaked at $443000.0 during Q4 2021, and registered a low of $399000.0 during Q4 2020.
- Over the past 5 years, Syndax Pharmaceuticals' median Accumulated Depreciation & Amortization value was $411000.0 (recorded in 2023), while the average stood at $414200.0.
- In the last 5 years, Syndax Pharmaceuticals' Accumulated Depreciation & Amortization skyrocketed by 2870.97% in 2020 and then tumbled by 993.23% in 2022.
- Syndax Pharmaceuticals' Accumulated Depreciation & Amortization (Quarter) stood at $399000.0 in 2020, then grew by 11.03% to $443000.0 in 2021, then fell by 9.93% to $399000.0 in 2022, then increased by 3.01% to $411000.0 in 2023, then grew by 1.95% to $419000.0 in 2024.
- Its Accumulated Depreciation & Amortization was $419000.0 in Q4 2024, compared to $411000.0 in Q4 2023 and $399000.0 in Q4 2022.